Enabling Comprehensive Insights with Digital Pathology

Discovery Life Sciences

Discovery Life Sciences supports biopharma organizations with biomarker and translational research services spanning molecular pathology, immunohistochemistry, multiplex immunofluorescence, and digital pathology. Discovery also operates one of the industry's largest and extensively characterized biospecimen repositories, giving biopharma partners a single point of access from sample sourcing through downstream biomarker analysis.

Modern biomarker research is increasingly adopting digital pathology to turn high-quality images into untapped scientific insights. As digital pathology and AI-powered image analysis continue to evolve, researchers are unlocking information faster and beyond what was possible with traditional methods.

In this video, Discovery Life Sciences speaks to their experiences integrating digital imaging and image analysis workflows, enabling their pharmaceutical clients to advance scientific discovery. Their team highlights various benefits of using the Aperio FL 120 scanner to efficiently scan large volumes of slides, automatically identify and focus on regions of interest, and generate high-resolution fluorescence images required for FISH and multiplex assays. What once required long hours of manual effort can now be completed in a fraction of the time. Combined with seamless integration into the HALO image analysis platform, they rapidly transform complex pathology images into meaningful, quantitative insights, enabling patterns to emerge before the final scan batch is complete.

View More Customer Stories here: Customer Testimonials - YouTube

Learn more about Discovery Life Sciences.